3D Global Biotech Inc. (TPEX:6808)

Taiwan · Delayed Price · Currency is TWD

31.50

-0.40 (-1.25%)

Apr 20, 2026, 9:45 AM CST

-37.99% (1Y)

Market Cap	2.48B -50.8%
Revenue (ttm)	206.74M -22.2%
Net Income	66.53M -27.5%
EPS	0.84 -35.4%
Shares Out	77.84M
PE Ratio	37.98
Forward PE	n/a
Dividend	0.53 (1.66%)
Ex-Dividend Date	n/a

Volume	1
Average Volume	146,648
Open	31.90
Previous Close	31.90
Day's Range	31.50 - 31.90
52-Week Range	30.15 - 63.00
Beta	0.30
RSI	38.70
Earnings Date	Apr 23, 2026

About 3D Global Biotech

3D Global Biotech Inc. manufactures and sells medical devices for human body reconstruction. It offers artificial bone grafting; 3D bioForming; bio-dressing; 3D bioture EX; 3D printing equipment, such as 3D BioRealizer system; orthodontic aligner system under the SmileAlign name; and iMatrix, a sectional matrix kit. The company was founded in 2014 and is based in New Taipei City, Taiwan. [Read more]

Industry Biotechnology

Sector Healthcare

Founded 2014

Employees 43

Stock Exchange Taipei Exchange

Ticker Symbol 6808

Full Company Profile

Financial Performance

In 2025, 3D Global Biotech's revenue was 206.74 million, a decrease of -22.19% compared to the previous year's 265.69 million. Earnings were 66.53 million, a decrease of -27.45%.

Financial Statements